US · Healthcare

Upstream Bio, Inc. (UPB)

Biotechnology

Upstream Bio, Inc. (UPB) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for UPB

P/E ratio
18.00

Upstream Bio, Inc. (UPB) — FAQ

What is UPB's P/E ratio?

The price-to-earnings (P/E) ratio for Upstream Bio, Inc. (UPB) is 18.00 (data as of 2026-03-24).

Does Upstream Bio, Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Upstream Bio, Inc. (UPB). Check the MyAverix Finance app for the latest dividend data.

What sector is Upstream Bio, Inc. in?

Upstream Bio, Inc. (UPB) is classified in the Healthcare sector (Biotechnology industry).

What exchange is UPB listed on?

UPB is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play